Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
Konjugation:
Unconjugated
Alternative Synonym:
2019 peak N Protein, 2019-nCoV N, 2019-nCoV N Protein, 2019-nCoV Nucleoprotein, 2019-nCoV nucleocapsid protein., 2019nCoV N, SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid Protein, novel coronavirus N Protein, novel coronavirus Nucleocapsid Protein, nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2], sars-cov-2
Lyophilized from 0.22 im filtered solution in PBS, pH 7.4 . Normally trehalose is added as protectant before lyophilization.
Formulierung:
Lyophilized
Target-Kategorie:
N
Anwendungsbeschreibung:
Application Notes: This antibody can be paired with other Anti-SARS-CoV-2 Nucleocapsid antibodies to detect SARS-CoV-2 Nucleocapsid protein in sandwich ELISA or LFA assay
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized SARS-CoV-2 Nucleocapsid protein, His Tag at 2 ug/mL (100 uL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 with a linear range of 0.08-1 ng/mL (QC tested).
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
